CDSCO
- Status: likely_approved
🇮🇳 Carvykti in India
Carvykti (ciltacabtagene autoleucel) regulatory status in India.
Marketing authorisation
Carvykti in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in India
Frequently asked questions
Is Carvykti approved in India?
Yes. CDSCO has authorised it.
Who is the marketing authorisation holder for Carvykti in India?
Johnson & Johnson is the originator. The local marketing authorisation holder may differ — check the official source linked above.